Apellis Pharmaceuticals (NASDAQ:APLS) General Counsel Sells $100,300.00 in Stock
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) General Counsel David Watson sold 5,000 shares of Apellis Pharmaceuticals stock in a transaction on Monday, November 17th. The stock was...